Clinical Research Directory
Browse clinical research sites, groups, and studies.
Metformin in Safety and Efficacy in Gouty Patients
Sponsor: Mostafa Bahaa
Summary
The most frequent crystal arthropathy is gout, which is also the most prevalent cause of inflammatory arthritis. Gouty Patients frequently have excruciating pain and swelling in their joints. Gout is linked to decreased health-related quality of life and functional disability. Gout and its associated diseases have been shown to have a significant impact on patients mortality and morbidities. Metformin, a biguanide, is used to manage diabetes by reducing insulin resistance and preventing comorbidities such as cerebrovascular and coronary artery disease, as well as providing renal protection to diabetic nephropathy patients
Official title: the Impact of Metformin Use on Clinical Outcomes in Gouty Patients
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2025-04-20
Completion Date
2026-11-20
Last Updated
2025-06-27
Healthy Volunteers
No
Conditions
Interventions
placebo
Placebo will have the same look of metformin
Metformin
Metformin, a biguanide, is used to manage diabetes by reducing insulin resistance and preventing comorbidities such as cerebrovascular and coronary artery disease, as well as providing renal protection to diabetic nephropathy patients
Locations (1)
Tanta Unuversity
Tanta, Egypt